icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025
 		Back grey_arrow_rt.gif
 
 
 
Current status of LA/ER Cabotegravir (CAB) and Rilpivirine including pipeline report
 
 
  at LEAP 2025 March 8 SF

0311251

0311252

0311253

0311254

0311255

0311256

0311257

0311258